Therapeutic Effect of Combination Treatment of Antihistamine and Montelukast in Allergic Rhinitis
Journal of Rhinology
;
: 20-25, 2013.
Article
in Korean
| WPRIM
| ID: wpr-14327
ABSTRACT
BACKGROUND:
Montelukast is a type 1 cysteinyl-leukotrienes receptor antagonist that has been widely used in allergic disease. However, the effect of combination of leukotriene receptor antagonist and antihistamine is controversial. The aim of this study was to compare the effect of combination treatment of montelukast and antihistamine, fexofenadine, over antihistamine alone in patients with allergic rhinitis (AR). SUBJECTS ANDMETHODS:
Retrospective chart review of 60 patients with AR was undertaken. Patients were classified into combination group (montelukast and fexofenadine, n=28) and antihistamine only group (fexofenadine, n=32) according to treatment modalities. Questionnaire survey was performed and allergic symptoms (VAS scale, 5pointscale), and SNOT (sinonasal outcome test)-20 score were obtained before and after the treatment.RESULTS:
Mean follow-up duration was 6.7+/-4.6weeks. There was no significant difference in demographic data between two groups. Allergic symptoms and SNOT-20 score(nasal, QOL domain) were improved significantly in both groups after the treatment (all p 0.05, respectively).CONCLUSION:
A combination treatment of montelukast and fexofenadine showed more efficacies in nasal obstruction than single fexofenadine treatment in patients with AR. Therefore, montelukast could be used effectively with antihistamine in patients with AR complaining nasal congestion.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Quinolines
/
Nasal Obstruction
/
Rhinitis
/
Rhinitis, Allergic, Perennial
/
Surveys and Questionnaires
/
Retrospective Studies
/
Follow-Up Studies
/
Terfenadine
/
Receptors, Leukotriene
/
Estrogens, Conjugated (USP)
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
Korean
Journal:
Journal of Rhinology
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS